Bencze WL, Hess R, DeStevens G (6 December 2012). "Hypolipidemic agents". Progress in Drug Research. Fortschritte der ... It is metabolized into isoniazid, an anti-tuberculosis agent, and so is contraindicated in patients with tuberculosis. The ...

... is a sulfamylbenzoic acid that acts as a hypolipidemic agent. Although it was found to be more powerful than ... "Hypolipidemic Agents". Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches ... Hypolipidemic agents, Sulfonamides, Abandoned drugs, Benzoic acids). ...

Antibodies, Hypolipidemic agents). ...

... is a hypolipidemic agent. Potì R, Quintavalla R, Manotti C (1977). "[Clinical experimentation with a new drug lowering ... Hypolipidemic agents, All stub articles, Cardiovascular system drug stubs). ...

... is a hypolipidemic agent. Levine, W.G.; Meijer, D.K.F. (1977), "THE CHOLERETIC EFFECT OF NAFENOPIN", Abstracts, ...

... is a fibrate, a hypolipidemic agent. It is a combined ester of clofibric acid and niacin (nicotinic acid) with 1,3- ...

Pharmacological therapies include hypolipidemic agents, thrombolytics and anticoagulants. Pharmacological options for reducing ... "Regulation of ET-1 biosynthesis in cerebral microvascular endothelial cells by vasoactive agents and PKC". American Journal of ... "Subarachnoid Hematoma Attenuates Vasodilation and Potentiates Vasoconstriction Induced by Vasoactive Agents in Newborn Pigs". ... "Subarachnoid Hematoma Attenuates Vasodilation and Potentiates Vasoconstriction Induced by Vasoactive Agents in Newborn Pigs". ...

... is a niacin derivative used as a hypolipidemic agent. It is an ester of pentaerythritol and nicotinic acid, has ...

... is a niacin derivative used as a hypolipidemic agent. Kopelevich VM, Gunar VI (1999). "Some approaches to the ...

Roth BD (2002). The discovery and development of atorvastatin, a potent novel hypolipidemic agent. Progress in Medicinal ... "Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients ... an effective lipid-modifying agent in familial hypercholesterolemia". Arteriosclerosis, Thrombosis, and Vascular Biology. 17 (8 ...

1. Hypolipidemic and hypoglycemic agents with ability to inhibit lipid peroxidation". Journal of Medicinal Chemistry. 32 (2): ...

... a Potent Novel Hypolipidemic Agent". Progress in Medicinal Chemistry. 40: 1-22. doi:10.1016/S0079-6468(08)70080-8. ISBN 978-0- ... a Potent Novel Hypolipidemic Agent". Prog. Med. Chem. Progress in Medicinal Chemistry. 40: 1-22. doi:10.1016/S0079-6468(08) ...

... is a niacin derivative used as a hypolipidemic agent. Budavari S, O'Neil M, Smith A, Heckelman P, ...

... (trade name Sedalipid) is a hypolipidemic agent. Schuitemaker GE, van der Pol GA, ... Hypolipidemic agents, All stub articles, Cardiovascular system drug stubs). ...

All articles with unsourced statements, Articles with unsourced statements from December 2015, Hypolipidemic agents). ...

... (compactin, ML-236B) is a hypolipidemic agent that belongs to the statins class. It was isolated from the mold ...

... is a derivative of acefylline and clofibrate used as a hypolipidemic agent. FR 2393803, Tamietto, Teresio ...

... a new hypolipidemic agent, on biliary and serum lipids in patients with hyperlipidemia". Atherosclerosis. 42 (2-3): 129-39. doi ...

... (pyridylcarbinol) is a niacin derivative used as a hypolipidemic agent and as a vasodilator. It causes ... At least a couple of uses for this agent were discovered over the years: Eniclobrate Mepiroxol Nicofibrate Pantenicate ( ...

In the body it is converted into 4-chlorophenoxyisobutyric acid (clofibric acid), which is the true hypolipidemic agent. So ...

... and are therefore hypolipidemic agents. Fibrates improve atherogenic dyslipidemia characterized by high triglyceride and/or low ... Clinical trials do support their use as monotherapy agents. Fibrates reduce the number of non-fatal heart attacks, but do not ...

Lipid-lowering agents, also sometimes referred to as hypolipidemic agents, cholesterol-lowering drugs, or antihyperlipidemic ... Flaxseed oil Investigational classes of hypolipidemic agents: CETP inhibitors (cholesteryl ester transfer protein), 1 candidate ... lipid lowering agent' be used for this class of drugs rather than the term 'hypolipidemic'. The several classes of lipid ... the choice of an agent depends on the patient's cholesterol profile, cardiovascular risk, and the liver and kidney functions of ...

Use of these agents as hypolipidemic agents has decreased markedly since the introduction of the statins, which are more ... In general, they are classified as hypolipidemic agents, although they may be used for purposes other than lowering cholesterol ...

Hypolipidemic agents, Benzoate esters, Substituted amphetamines, Trifluoromethyl compounds, Monoamine releasing agents, ... Benfluorex, sold under the brand name Mediator, is an anorectic and hypolipidemic agent that is structurally related to ...

... is a hypolipidemic agent. It occurs free in Crotalaria dura and C. globifera and is bound in dicrotaline (pyrrolizidine ... Hypolipidemic agents, Aldols, All stub articles, Cardiovascular system drug stubs). ...

In trophoblast-derived cell lines, up-regulated VLDLR expression occurs when cells are incubated with hypolipidemic agents such ...

Hypolipidemic agents, Discontinued products). ...

1994). Novel nematocidal agents from Curcuma comosa. J Nat Prod 57(2): 250-262. Suksamrarn, A., et al. (1997) A ... 1997). Hypolipidemic effect of Curcuma comosa in mice. Artery 22(5): 233-241. Piyachaturawat, P., J. Charoenpiboonsin, C. ...

... mainly as hypolipidemic agents, although they may be used for purposes other than lowering cholesterol. Solvent impregnated ...

Hypolipidemic agents, 3-Pyridyl compounds, Multiple Chemboxes). ... Costet P (June 2010). "Molecular pathways and agents for ... How effective are the different agents?". European Heart Journal Supplements. 8 (F): F47-F53. doi:10.1093/eurheartj/sul041. ... "Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid". Cell Metabolism. 12 (4): 411 ...